A mixed‐methods study of cyclin‐dependent kinase 4 and 6 inhibitor symptom burden and quality of life among metastatic breast cancer patients and providers by Laura B. Oswald, Brandy Arredondo, Mika Kadono, Dinorah Martinez‐Tyson, Cathy D. Meade, Frank Penedo, Michael H. Antoni, Hatem Soliman, Ricardo L. B. Costa, Heather S. L. Jim

Get full text